Drawing for MEZZION

USPTO serial 88174398

MEZZION

Reviewed by CopyMark Law Group

Reg. 6115846Status 702Renewal
Filing date
Status date
Registration date
Aug 4, 2020
Examiner
MARTIN, CHRISTINE C
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MEZZION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ryan O'Quinn

Ryan O'Quinn Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue NWWashington, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation ]ACTIVE—
042Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation ; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for othersACTIVE—
044Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan PalliationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 14, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 14, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 4, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Aug 4, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 23, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Aug 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 29, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 29, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 29, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 29, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 29, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 4, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 13, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 13, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 10, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 3, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 2, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 31, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 31, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 27, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 10, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 10, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 10, 2020CNSISUSPENSION INQUIRY WRITTEN—
Feb 10, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 2, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 2, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Aug 2, 2019CNSLSUSPENSION LETTER WRITTEN—
Jul 31, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 31, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2019ALIEASSIGNED TO LIE—
Jul 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2019DOCKASSIGNED TO EXAMINER—
Jan 11, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 11, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 4, 2019TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 4, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance